The Human Medicines Regulations 2012 No. 1916

PART 17 U.K. Miscellaneous and general

Transitional provisions, savings, amendments, repeals and revocations U.K.

Transitional provisions and savings U.K.

347.  Schedule 32 contains transitional provisions and savings.

[F1 Transitional provision in relation to EU exit U.K.

347A.   Schedule 33A contains transitional provision in relation to the EU Exit Regulations.]

Textual Amendments

F1 Reg. 347A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 228(1); 2020 c. 1, Sch. 5 para. 1(1)

[F2 Transitional provision relating to the Windsor Framework U.K.

347B.— (1) Schedule 33B contains transitional provision in relation to the implementation of the Windsor Framework.

(2) In paragraph (1), “the Windsor Framework” means the part of the withdrawal agreement known as the Windsor Framework by virtue of Joint Declaration No. 1/2023 of 24 March 2023 made between the European Union and the United Kingdom in the Joint Committee established by the withdrawal agreement.]

Textual Amendments

F2 Reg. 347B inserted (1.1.2025) by The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 133

Amendments to existing law U.K.

348.  Schedule 34 contains amendments to existing law.

Repeals and revocations U.K.

349.  Schedule 35 contains repeals and revocations.